The Nonclinical Drug Safety (NDS) division at our company is seeking a motivated and talented in vitro pharmacologist/physiologist with experience in the development and characterization of Novel Alternative Methods (NAMs) to support nonclinical safety pharmacology and functional toxicity assessments. The Safety & Exploratory Pharmacology department (SEP) collaborates with our discovery research, preclinical, and clinical development partners to identify and develop effective, safe therapeutics. To that end, SEP utilizes a purposeful blend of standard screening tools, regulatory-enabling assays, fit for purpose capabilities and forward-looking innovative solutions to understand potential major organ system pharmacodynamic risk and influence drug development strategy. To enhance that mission, we are looking for a PhD level individual contributor that will complement existing areas, expand the team’s expertise, help drive future innovation, and influence the external scientific and regulatory community. The successful candidate will have demonstrated experience in the development and application of NAMs (ex: Complex In Vitro Models, Organ-on-a-chip, or Tissue Engineered Models, or Organoids) that use functional endpoints to characterize effects of new molecular entities. The individual also will possess the attributes and interest to expand their career toward a broader strategic Nonclinical Drug Safety role. This may include future development toward opportunities in management/leadership roles within SEP and/or as the nonclinical safety lead on discovery or clinical development programs.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree